Licochalcone E has an antidiabetic effect

Journal of Nutritional Biochemistry

Volumn 23, Issue 7, 2012, Pages 759-767

  Park, Hong Gyu ^a,b,h   Bak, Eun Jung ^a   Woo, Gye Hyeong ^c   Kim, Jin Moon ^a,d   Quan, Zhejiu ^a   Kim, Jung Mogg ^b   Yoon, Ho Kun ^d   Cheon, Seung Hoon ^e   Yoon, Goo ^f   Yoo, Yun Jung ^a,d   Na, Younghwa ^g   Cha, Jeong Heon ^a,d  

^a Yonsei University College of Dentistry   (South Korea)

^b Hanyang University College of Medicine   (South Korea)

^c Semyung University   (South Korea)

^d Yonsei University   (South Korea)

^e Chonnam National University   (South Korea)

^f Mokpo National University   (South Korea)

^g CHA University   (South Korea)

^h ATGC Biotechnology Co Ltd   (South Korea)

Author keywords

Adipocyte differentiation; Diabetes; Licochalcone E; Obesity

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; LICOCHALCONE E; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT MEDICINAL PRODUCT; PROTEIN KINASE B; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OBESITY; PROADIPOCYTE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL; TRIACYLGLYCEROL BLOOD LEVEL; WHITE ADIPOSE TISSUE;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE, WHITE; ANIMALS; CELL DIFFERENTIATION; CHALCONES; DIABETES MELLITUS; GLYCYRRHIZA; HYPOGLYCEMIC AGENTS; MALE; MICE; MICE, INBRED C57BL; PLANT EXTRACTS; PLANT ROOTS; PPAR GAMMA; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRIGLYCERIDES;

GLYCYRRHIZA INFLATA; MUS;

EID: 84862334556     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.03.021     Document Type: Article

References (37)

1. Frayn K.N. Adipose tissue and the insulin resistance syndrome. Proc Nutr Soc 2001, 60:375-380.
2. Yu Z.K., Wright J.T., Hausman G.J. Preadipocyte recruitment in stromal vascular cultures after depletion of committed preadipocytes by immunocytotoxicity. Obes Res 1997, 5:9-15.
3. Young H.E., Mancini M.L., Wright R.P., Smith J.C., Black A.C., Reagan C.R., et al. Mesenchymal stem cells reside within the connective tissues of many organs. Dev Dyn 1995, 202:137-144.
4. Caplan A.I. Mesenchymal stem cells. J Orthop Res 1991, 9:641-650.
5. Green H., Kehinde O. Sublines of mouse 3T3 cells that accumulate lipid. Cell 1974, 1:113-115.
6. Green H., Kehinde O. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 1975, 5:19-27.
7. Green H., Kehinde O. Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell 1976, 7:105-113.
8. Reznikoff C.A., Brankow D.W., Heidelberger C. Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res 1973, 33:3231-3238.
9. Pinney D.F., Emerson C.P. 10T1/2 cells: an in vitro model for molecular genetic analysis of mesodermal determination and differentiation. Environ Health Perspect 1989, 80:221-227.
10. Bowers R.R., Kim J.W., Otto T.C., Lane M.D. Stable stem cell commitment to the adipocyte lineage by inhibition of DNA methylation: role of the BMP-4 gene. Proc Natl Acad Sci U S A 2006, 103:13022-13027.
11. Olefsky J.M. The effects of spontaneous obesity on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes. J Clin Invest 1976, 57:842-851.
12. Sreenan S., Sturis J., Pugh W., Burant C.F., Polonsky K.S. Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone. Am J Physiol 1996, 271:E742-E747.
13. Stevenson R.W., Hutson N.J., Krupp M.N., Volkmann R.A., Holland G.F., Eggler J.F., et al. Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice. Diabetes 1990, 39:1218-1227.
14. Koren S., Fantus I.G. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus. Best Pract Res Clin Endocrinol Metab 2007, 21:621-640.
15. Montalibet J., Kennedy B.P. Therapeutic strategies for targeting PTP1B in diabetes. Drug Discovery Today: Therapeutic Strategies 2005, 2:129-135.
16. Ayabe S.I., Yoshikawa T., Kobayashi M., Furuya T. Biosynthesis of a retrochalcone, echinatin: involvement of O-methyltransferase to licodione. Phytochemistry 1980, 19:2331-2336.
17. Yoon G., Jung Y.D., Cheon S.H. Cytotoxic allyl retrochalcone from the roots of Glycyrrhiza inflata. Chem Pharm Bull (Tokyo) 2005, 53:694-695.
18. Na Y., Cha J.H., Yoon H.G., Kwon Y. A concise synthesis of licochalcone E and its regio-isomer, licochalcone F. Chem Pharm Bull (Tokyo) 2009, 57:607-609.
19. Student A.K., Hsu R.Y., Lane M.D. Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. J Biol Chem 1980, 255:4745-4750.
20. Lee J.S., Suh J.M., Park H.G., Bak E.J., Yoo Y.J., Cha J.H. Heparin-binding epidermal growth factor-like growth factor inhibits adipocyte differentiation at commitment and early induction stages. Differentiation 2008, 76:478-487.
21. Bak E.J., Park H.G., Kim J.M., Kim J.M., Yoo Y.J., Cha J.H. Inhibitory effect of evodiamine alone and in combination with rosiglitazone on in vitro adipocyte differentiation and in vivo obesity related to diabetes. Int J Obes (Lond) 2010, 34:250-260.
22. Kim J.B., Wright H.M., Wright M., Spiegelman B.M. ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. Proc Natl Acad Sci U S A 1998, 95:4333-4337.
23. Madsen L., Petersen R.K., Sorensen M.B., Jorgensen C., Hallenborg P., Pridal L., et al. Adipocyte differentiation of 3T3-L1 preadipocytes is dependent on lipoxygenase activity during the initial stages of the differentiation process. Biochem J 2003, 375:539-549.
24. Nugent C., Prins J.B., Whitehead J.P., Savage D., Wentworth J.M., Chatterjee V.K., et al. Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation. Mol Endocrinol 2001, 15:1729-1738.
25. Mae T., Kishida H., Nishiyama T., Tsukagawa M., Konishi E., Kuroda M., et al. A licorice ethanolic extract with peroxisome proliferator-activated receptor-gamma ligand-binding activity affects diabetes in KK-Ay mice, abdominal obesity in diet-induced obese C57BL mice and hypertension in spontaneously hypertensive rats. J Nutr 2003, 133:3369-3377.
26. Kim T.H., Kim H., Park J.M., Im S.S., Bae J.S., Kim M.Y., et al. Interrelationship between liver X receptor alpha, sterol regulatory element-binding protein-1c, peroxisome proliferator-activated receptor gamma, and small heterodimer partner in the transcriptional regulation of glucokinase gene expression in liver. J Biol Chem 2009, 284:15071-15083.
27. Takahashi N., Kawada T., Goto T., Yamamoto T., Taimatsu A., Matsui N., et al. Dual action of isoprenols from herbal medicines on both PPARgamma and PPARalpha in 3T3-L1 adipocytes and HepG2 hepatocytes. FEBS Lett 2002, 514:315-322.
28. Kliewer S.A., Forman B.M., Blumberg B., Ong E.S., Borgmeyer U., Mangelsdorf D.J., et al. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci U S A 1994, 91:7355-7359.
29. Yoon G., Lee W., Kim S.N., Cheon S.H. Inhibitory effect of chalcones and their derivatives from Glycyrrhiza inflata on protein tyrosine phosphatase 1B. Bioorg Med Chem Lett 2009, 19:5155-5157.
30. Sakaue H., Ogawa W., Matsumoto M., Kuroda S., Takata M., Sugimoto T., et al. Posttranscriptional control of adipocyte differentiation through activation of phosphoinositide 3-kinase. J Biol Chem 1998, 273:28945-28952.
31. Whiteman E.L., Cho H., Birnbaum M.J. Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab 2002, 13:444-451.
32. Krook A., Kawano Y., Song X.M., Efendic S., Roth R.A., Wallberg-Henriksson H., et al. Improved glucose tolerance restores insulin-stimulated Akt kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kakizaki rats. Diabetes 1997, 46:2110-2114.
33. Krook A., Roth R.A., Jiang X.J., Zierath J.R., Wallberg-Henriksson H. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes 1998, 47:1281-1286.
34. Park S.Y., Shin H.K., Lee J.H., Kim C.D., Lee W.S., Rhim B.Y., et al. Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription. J Pharmacol Exp Ther 2009, 329:571-579.
35. Fritzius T., Moelling K. Akt- and Foxo1-interacting WD-repeat-FYVE protein promotes adipogenesis. EMBO J 2008, 27:1399-1410.
36. Peng X.D., Xu P.Z., Chen M.L., Hahn-Windgassen A., Skeen J., Jacobs J., et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 2003, 17:1352-1365.
37. Baudry A., Yang Z.Z., Hemmings B.A. PKBalpha is required for adipose differentiation of mouse embryonic fibroblasts. J Cell Sci 2006, 119:889-897.